NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 117 filers reported holding NUVATION BIO INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,222,120 | +62530.2% | 761,000 | -21.9% | 0.00% | -33.3% |
| Q1 2024 | $3,548 | +58.4% | 974,700 | -34.3% | 0.01% | +100.0% |
| Q4 2023 | $2,240 | +328.3% | 1,483,131 | +280.3% | 0.00% | +200.0% |
| Q3 2023 | $523 | -6.8% | 390,000 | +25.0% | 0.00% | 0.0% |
| Q2 2023 | $561 | +23.8% | 311,900 | +14.2% | 0.00% | 0.0% |
| Q1 2023 | $453 | +63.5% | 273,100 | +89.4% | 0.00% | – |
| Q4 2022 | $277 | -100.0% | 144,200 | -44.6% | 0.00% | -100.0% |
| Q3 2022 | $584,000 | +108.6% | 260,515 | +201.9% | 0.00% | – |
| Q2 2022 | $280,000 | -42.3% | 86,300 | -6.4% | 0.00% | -100.0% |
| Q1 2022 | $485,000 | +14.9% | 92,200 | +85.9% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | -15.8% | 49,600 | -1.6% | 0.00% | 0.0% |
| Q3 2021 | $501,000 | -88.5% | 50,400 | -89.2% | 0.00% | -80.0% |
| Q2 2021 | $4,346,000 | – | 466,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |